Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
Howman
Rebecca
R
Department of Haemotology, Fremantle Hospital, 2 Alma Street, Fremantle, Western Australia 6160.
Kulkarni
Hemant
H
D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000906:Antibodies / Q000009:adverse effects* / Q000276:immunology; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology / Q000627:therapeutic use; D017809:Fatal Outcome; D006397:Hematinics / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D009894:Opportunistic Infections / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000276:immunology
D000906:Antibodies; D006397:Hematinics; D007166:Immunosuppressive Agents; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D003520:Cyclophosphamide; D011239:Prednisolone